The budget’s emphasis on Ease of Doing Business and local manufacturing is welcome. In particular, the ₹1 lakh crore R&D allocation for sunrise sectors can act as a catalyst in our innovation journey as the Indian pharma industry aims to reach $120-130 billion by 2030.